Literature DB >> 18541716

Relationship of spinal dynorphin neurons to delta-opioid receptors and estrogen receptor alpha: anatomical basis for ovarian sex steroid opioid antinociception.

Alan R Gintzler1, Stephen A Schnell, Daya S Gupta, Nai-Jiang Liu, Martin W Wessendorf.   

Abstract

Pharmacological and behavioral studies suggest that spinal delta- and kappa-opioid antinociceptive systems are functionally associated with ovarian sex steroids. These interactions can be demonstrated specifically during pregnancy or hormone-simulated pregnancy (HSP). The analgesia associated with both conditions can be abolished by blockade of either spinal kappa-opioid receptors or delta-opioid receptors (DOR). Furthermore, both dynorphin (DYN) release (J Pharmacol Exp Ther 298:1213-1220, 2001) and the processing of the DYN precursor (J Neurochem 65:1374-1380, 1995) are significantly increased in the spinal cord during HSP. We undertook the current study to determine whether DYN, DOR, and estrogen receptor alpha (ERalpha) share anatomical relationships that permit their direct interaction. Coexpression of DOR or ERalpha by DYN neurons was assessed using fluorescence immunohistochemistry and a synaptosomal release assay. Findings show that ERalpha and DYN are coexpressed. Moreover, in the spinal cord of HSP animals, there were significant increases in the number of DYN-immunoreactive (DYN-ir) cells, ERalpha-ir cells, cells double-labeled for DYN-ir and ERalpha-ir and the proportion of DYN-ir cells coexpressing ERalpha. Some varicose fibers in the spinal cord dorsal horn and intermediate gray matter that expressed DYN-ir also expressed DOR-ir. Activation of DORs located on DYN terminals was sufficient to inhibit K(+)-evoked DYN release. These data define, at least in part, the anatomical substrates that may be relevant to the antinociception of gestation and its hormonal simulation. Furthermore, they provide a framework for understanding sex-based nociception and antinociception and suggest novel strategies for treating pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541716     DOI: 10.1124/jpet.108.139816

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Regulation of spinal dynorphin 1-17 release by endogenous pituitary adenylyl cyclase-activating polypeptide in the male rat: relevance of excitation via disinhibition.

Authors:  Nai-Jiang Liu; Stephen A Schnell; Stefan Schulz; Martin W Wessendorf; Alan R Gintzler
Journal:  J Pharmacol Exp Ther       Date:  2010-10-25       Impact factor: 4.030

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  Spinal synthesis of estrogen and concomitant signaling by membrane estrogen receptors regulate spinal κ- and μ-opioid receptor heterodimerization and female-specific spinal morphine antinociception.

Authors:  Nai-Jiang Liu; Sumita Chakrabarti; Stephen Schnell; Martin Wessendorf; Alan R Gintzler
Journal:  J Neurosci       Date:  2011-08-17       Impact factor: 6.167

Review 4.  Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors.

Authors:  Alan R Gintzler; Nai-Jiang Liu
Journal:  Front Neuroendocrinol       Date:  2012-10-02       Impact factor: 8.606

5.  Direct inhibition of arcuate proopiomelanocortin neurons: a potential mechanism for the orexigenic actions of dynorphin.

Authors:  Xiaobing Zhang; Anthony N van den Pol
Journal:  J Physiol       Date:  2013-01-14       Impact factor: 5.182

6.  Plasticity of Signaling by Spinal Estrogen Receptor α, κ-Opioid Receptor, and Metabotropic Glutamate Receptors over the Rat Reproductive Cycle Regulates Spinal Endomorphin 2 Antinociception: Relevance of Endogenous-Biased Agonism.

Authors:  Nai-Jiang Liu; Vijaya Murugaiyan; Emiliya M Storman; Stephen A Schnell; Arjun Kumar; Martin W Wessendorf; Alan R Gintzler
Journal:  J Neurosci       Date:  2017-10-12       Impact factor: 6.167

7.  Estradiol treatment prevents injury induced enhancement in spinal cord dynorphin expression.

Authors:  Daya S Gupta; Charles H Hubscher
Journal:  Front Physiol       Date:  2012-02-22       Impact factor: 4.566

8.  Examination of sex and minocycline treatment on acute morphine-induced analgesia and inflammatory gene expression along the pain pathway in Sprague-Dawley rats.

Authors:  Caitlin K Posillico; Laurne S Terasaki; Staci D Bilbo; Jaclyn M Schwarz
Journal:  Biol Sex Differ       Date:  2015-12-12       Impact factor: 5.027

Review 9.  Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.

Authors:  Elena H Chartoff; Maria Mavrikaki
Journal:  Front Neurosci       Date:  2015-12-16       Impact factor: 4.677

10.  Why We Still Need To Speak About Sex Differences and Sex Hormones in Pain.

Authors:  Anna Maria Aloisi
Journal:  Pain Ther       Date:  2017-10-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.